Revolutionizing Commercial Aliquotation in Advanced Therapies

Modular filling enabling process flexibility for viral vector manufacturing

We are thrilled to unveil our latest customized innovation within the product range of automated aliquoting systems, RoSS.FILL. This groundbreaking solution is set to redefine the way small volumes are dispensed into single-use bags at a commercial scale. With its unmatched precision and cutting-edge technology, RoSS.FILL CGT is a game-changer for the cell and gene therapy industry.

Many Bags. Small Volumes.

At Single Use Support, we understand the critical importance of accuracy and efficiency in the manufacturing process of advanced therapies, including non-viral and viral vectors. Thanks to the modularity of the RoSS.FILL platforms, it is possible to address the unique challenges faced by researchers and manufacturers in this rapidly advancing field. 

Filling up to 126 single-use bioprocess containers with 3mL to 100mL each, this revolutionary system sets a new standard for precision and reliability.

Highest Precision

RoSS.FILL CGT leverages state-of-the-art technology to ensure that even the smallest volumes are handled with utmost precision. Using flow sensors, filling accuracy can be down to ±0.5mL, when using typical filling volumes. Whether you are working with delicate gene therapies or intricate cell-based products, this modular solution guarantees accurate aliquotation and filling, eliminating the risk of variability and ensuring consistent product quality. The system is engineered to seamlessly integrate into existing workflows, allowing for effortless scalability and enhanced productivity. Say goodbye to complex and time-consuming manual processes and embrace a new era of efficiency.

Pioneering the biopharmaceutical industry, Single Use Support takes pride in developing innovative solutions that empower researchers and manufacturers to push the boundaries of possibility. RoSS.FILL CGT is a testament to our commitment to advancing the field of cell and gene therapies. Join us on this remarkable path and unlock the full potential of your cell and gene therapy manufacturing.